Guided Therapeutics (GTHP) Operating Margin Growth (5y) (2015 - 2025)
Guided Therapeutics (GTHP) Operating Margin Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 103,166.00 |
| Sep 30, 2025 | -60,963.00 |
| Dec 31, 2024 | -5.24 Mn |
| Mar 31, 2024 | -455,556.00 |
| Dec 31, 2023 | -44,658.00 |
| Jun 30, 2023 | 271,705.00 |
| Mar 31, 2023 | 556,818.00 |
| Sep 30, 2022 | -3.67 Mn |
| Jun 30, 2022 | -1.37 Mn |
| Mar 31, 2022 | -641,238.00 |
| Dec 31, 2021 | -95,422.00 |
| Sep 30, 2021 | -184,842.00 |
| Dec 31, 2020 | 1.60 Mn |
| Sep 30, 2020 | 2.28 Mn |
| Dec 31, 2019 | 1.55 Mn |
| Sep 30, 2019 | -782,273.00 |
| Jun 30, 2019 | -1.43 Mn |
| Mar 31, 2019 | 951,433.00 |
| Dec 31, 2018 | -67,887.00 |
| Sep 30, 2018 | -979,302.00 |